IL-1β mediates diethyldithiocarbamate-induced granulocyte colony- stimulating factor production and hematopoiesis

Experimental Hematology

Volumn 27, Issue 2, 1999, Pages 210-216

  Kennedy, Suzanne M ^a   Borch, Richard F ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Chemoprotection; Cytokines; Diethyldithiocarbamate; Human long term bone marrow cultures; Myelosuppression

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; DIETHYLDITHIOCARBAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; IL1RN PROTEIN, HUMAN; IL1RN PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; SIALOGLYCOPROTEIN;

ARTICLE; BONE MARROW CELL; BONE MARROW SUPPRESSION; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; MOUSE; PHYSIOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BONE MARROW CELLS; CELL LINE; DITIOCARB; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MICE; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 0032588701     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00033-2     Document Type: Article

References (46)

1. Borch R.F., Katz J., Lieder P., Pleasants M. Effect of diethyldithiocarbamate on tumor response to cis-platinum in a rat model. Proc Natl Acad Sci U S A. 77:1980;5441.
2. Schmalbach T., Borch R.F. Myeloprotective effect of diethyldithiocarbamate treatment following 1,3-Bis(2-chloroethyl)-1-nitrosourea, adriamycin, or mitomycin C in mice. Cancer Res. 49:1989;2574.
3. East C., Abboud C., Borch R.F. Diethyldithiocarbamate induction of cytokine release in human bone marrow cultures. Blood. 80:1992;1172.
4. Lenarsky C. Mechanisms in immune recovery after bone marrow transplantation. Am J Pediatr Hematol Oncol. 15:1993;49.
5. Dexter T.M., Allen T., Lajtha L. Conditions controlling the proliferation of hemopoietic stem cells in vitro. J Cell Physiol. 91:1977;335.
6. Allen T.D., Dexter T.M. Cellular interrelationships during in vitro granulopoiesis. Differentiation. 6:1976;191.
7. Gartner S., Kaplan H.S. Long-term culture of human bone marrow cells. Proc Natl Acad Sci U S A. 77:1980;4756.
8. Nishizawa M., Nagata S. Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol Cell Biol. 10:1990;2002.
9. Muller J., LomsZiegler-Heitbrock H., Baeuerle P. Nuclear factor-kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 187:1993;233.
10. Broudy V., Kaushansky K., Harlan J., Adamson J. Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol. 139:1987;464.
11. Vilcek J., Lee T. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 266:1991;7313.
12. Dinarello C. The interleukin-1 family. 10 years of discovery FASEB J. 8:1994;1314.
13. Orencole S., Dinarello C. Characterisation of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens. Cytokine. 1:1989;14.
14. Awni W., Hoff J., Shapiro B., Halstenson C. A dose-ranging pharmacokinetics study of sodium diethyldithiocarbamate in normal healthy volunteers. J Clin Pharmacol. 345:1994;1183.
15. Berry J., Jacobs C., Sikic B., Halsey J., Borch R. Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol. 8:1990;1585.
16. Gandara D., Nahhas W., Adelson N., Lichtman S., Podczaski E., Yanovich S., Homesley H., Braly P., Ritch P., Weisberg S., Williams L., Diasio R.et al. Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities. J Clin Oncol. 13:1995;490.
17. Paredes J., Hong W., Felder T., Dimery I., Choksi A., Newman R., Castellanos A., Robbins K., McCarthy D., Atkinson N., Kramer A., Hersh E.et al. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 6:1988;955.
18. Rothenburg M., Ostchega Y., Steinberg S., Young R., Hummel S., Ozols R. High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer. J Natl Cancer Inst. 80:1988;1488.
19. Qazi R., Chang A.Y., Borch R.F., Montine T., Dedon P., Loughner J., Bennett J.M. Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J Natl Cancer Inst. 80:1988;1486.
20. Chinery R., Brockman J., Peeler M., Shyr Y., Beauchamp R., Coffey R. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer. a p53-independent induction of p21 WAF1/CIP1 via C/EBPb Nature Med. 3:1997;1233.
21. Mangan D., Welch G., Wahl S. Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol. 146:1991;1541.
22. Newton R. Human monocyte production of interleukin-1. parameters of the induction of interleukin-1 secretion by lipopolysaccharides J Leukocyte Biol. 39:1986;299.
23. Slovick F., Abboud C., Brennan J., Lichtman M. Survival of granulocytic progenitors in the nonadherent and adherent compartments of human long-term marrow cultures. Exp Hematol. 12:1984;327.
24. Dignam J., Lebovitz R., Roeder R. Accurate transcription initiation by RNA polymerase II in a soluble extact from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475.
25. Aversa G., Punnonen J., deVries J. The 26-kD transmembrane form of tumor necrosis factor α on activated CD4+ T cell clones provides a co-stimulatory signal for human B cell activation. J Exp Med. 177:1993;1575.
26. Fenton M., Clark B., Collins K., Webb A., Rich A., Auron P. Transcriptional regulation of the human prointerleukin-1β gene. J Immunol. 138:1987;3972.
27. Fenton M.J. Review. transcriptional and post-transcriptional regulation of interleukin 1 gene expression Int J Immunopharm. 14:1992;401.
28. Buras J., Monks B., Fenton M. The NF-KB A-binding element, not an overlapping NF-IL-6-binding element, is required for maximal IL-1β gene expression. J Immunol. 152:1994;4444.
29. Sunderman F. The treatment of acute nickel carbonyl poisoning with sodium diethyldithiocarbamate. Ann Clin Res. 3:1971;182.
30. Evans R., Engel C., Wheatley C., Nielsen J., Ciborowski L. An in vivo study of the radioprotective effect of diethyldithiocarbamate. Radiat Oncol Biol Phys. 9:1983;1635.
31. Antin J., Weinstein H., Guinan E., McCarthy P., Bierer B., Gilliland D., Parsons S., Ballen K., Rimm I., Falzarano G., Bloedow D., Abate L.et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood. 84:1994;1342.
32. Crown J., Jakubowski A., Kemeny N., Gordon M., Gasparetto C., Wong G., Sheridan C., Toner G., Meisenberg B., Botet J., Applewhite J., Sinha S.et al. A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood. 78:1991;1420.
33. Elkordy M., Crump M., Vrendenburgh J., Petros W., Hussein A., Rubin P., Ross M., Gilbert C., Modlin C., Meisenberg B., Coniglio D., Rabinowitz J.et al. A phase I trial of recombinant human interleukin-1 beta (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant. 19:1997;315.
34. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A. 83:1986;1670.
35. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659.
36. Akashi M., Shaw G., Hachiya M., Elstner E., Suzuki G., Koeffler P. Number and location of AUUUA motifs. role in regulating transiently expressed RNAs Blood. 83:1994;3182.
37. Bohjanen P.R., Petryniak B., June C.H., Thompson C.B., Lindsten T. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol Cell Biol. 11:1991;3288.
38. Gillis P., Malter J.S. The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs. J Biol Chem. 266:1991;3172.
39. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells. AP-1 as secondary antioxidant-responsive factor EMBO J. 12:1993;2005.
40. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci U S A. 91:1994;1672.
41. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709.
42. Ziegler-Heitbrock H., Sternsdorf T., Liese J., Belohradsky B., Weber C., Wedel A., Schreck R., Bauerle P., Strobel M. Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol. 151:1993;6986.
43. Herzyk D., Allen J., Marsh C., Wewers M. Macrophage and monocyte IL-1β regulation differs at multiple sites. J Immunol. 149:1992;3052.
44. Lewis C., McCarthy S., Lorenzen J., O'DMcGee J. Heterogeneity among human mononuclear phagocytes in their secretion of lysozyme, interleukin 1 and type-beta transforming growth factor. a quantitative analysis at the single-cell level Eur J Immunol. 19:1989;2037.
45. Martin J., Edwards S. Changes in mechanisms of monocyte/macrophage mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol. 150:1993;3478.
46. Jongeneel C. Regulation of the TNF alpha gene. Prog Clin Biol Res. 388:1994;367.